{"entity":{"type":"insider","cik":"0001758842","url":"/insider/0001758842","json_url":"/insider/0001758842.json","name":"McAvoy David R.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":6,"first":"2020-06-22","last":"2025-09-09","span_basis":"filed_date"},"name_variants":[{"name":"McAvoy David R.","source":"filing","n_filings":6,"first_seen":"2020-06-22","last_seen":"2025-09-09"}],"transactions":[{"id":4264914,"accession":"0000950170-25-113800","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-113800","line_url":"/filing/0000950170-25-113800#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001758842","owner_name":"McAvoy David R.","owner_display_name":"McAvoy David R.","owner_url":"/insider/0001758842","role":"Officer (EVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1113.0,"shares_display":"1,113","price_per_share":18.8572,"price_display":"18.86","price_state":"stated","total_value":20988.0636,"total_display":"20,988.06","total_whole":"20,988","shares_owned_after":13027.0,"shares_owned_after_display":"13,027","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-05","filed_date":"2025-09-09","scope":"insider"},{"id":4910361,"accession":"0000950170-25-034670","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-25-034670","line_url":"/filing/0000950170-25-034670#line-3","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001758842","owner_name":"McAvoy David R.","owner_display_name":"McAvoy David R.","owner_url":"/insider/0001758842","role":"Officer (EVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1677.0,"shares_display":"1,677","price_per_share":15.9132,"price_display":"15.91","price_state":"stated","total_value":26686.4364,"total_display":"26,686.44","total_whole":"26,686","shares_owned_after":11914.0,"shares_owned_after_display":"11,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-06","scope":"insider"},{"id":4910358,"accession":"0000950170-25-034670","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-034670","line_url":"/filing/0000950170-25-034670#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001758842","owner_name":"McAvoy David R.","owner_display_name":"McAvoy David R.","owner_url":"/insider/0001758842","role":"Officer (EVP, Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Legal Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3150.0,"shares_display":"3,150","price_per_share":15.7346,"price_display":"15.73","price_state":"stated","total_value":49563.99,"total_display":"49,563.99","total_whole":"49,564","shares_owned_after":13591.0,"shares_owned_after_display":"13,591","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-06","scope":"insider"},{"id":5235252,"accession":"0000819050-21-000124","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000819050-21-000124","line_url":"/filing/0000819050-21-000124#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Brickell Biotech, Inc.","issuer_ticker":"BBI","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0001758842","owner_name":"McAvoy David R.","owner_display_name":"McAvoy David R.","owner_url":"/insider/0001758842","role":"Officer (General Counsel and CCO)","role_mark":"O","role_mark_label":"Officer (General Counsel and CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and CCO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18124.0,"shares_display":"18,124","price_per_share":0.6697,"price_display":"0.67","price_state":"stated","total_value":12137.6428,"total_display":"12,137.64","total_whole":"12,138","shares_owned_after":128879.0,"shares_owned_after_display":"128,879","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-23","filed_date":"2021-07-27","scope":"insider"},{"id":5494211,"accession":"0001062993-21-004867","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-21-004867","line_url":"/filing/0001062993-21-004867","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Brickell Biotech, Inc.","issuer_ticker":"BBI","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0001758842","owner_name":"McAvoy David R.","owner_display_name":"McAvoy David R.","owner_url":"/insider/0001758842","role":"Officer (General Counsel and CCO)","role_mark":"O","role_mark_label":"Officer (General Counsel and CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and CCO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26602.0,"shares_display":"26,602","price_per_share":0.8,"price_display":"0.80","price_state":"stated","total_value":21281.6,"total_display":"21,281.60","total_whole":"21,282","shares_owned_after":110755.0,"shares_owned_after_display":"110,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-17","filed_date":"2021-05-19","scope":"insider","n_lines":2},{"id":3242278,"accession":"0001062993-20-004584","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-20-004584","line_url":"/filing/0001062993-20-004584","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Brickell Biotech, Inc.","issuer_ticker":"BBI","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0001758842","owner_name":"McAvoy David R.","owner_display_name":"McAvoy David R.","owner_url":"/insider/0001758842","role":"Officer (General Counsel and CCO)","role_mark":"O","role_mark_label":"Officer (General Counsel and CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and CCO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22526.0,"shares_display":"22,526","price_per_share":0.8324635887418983,"price_display":"0.83","price_state":"stated","total_value":18752.0748,"total_display":"18,752.07","total_whole":"18,752","shares_owned_after":75883.0,"shares_owned_after_display":"75,883","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-18","filed_date":"2020-09-21","scope":"insider","n_lines":2},{"id":2463167,"accession":"0000911916-20-000136","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000911916-20-000136","line_url":"/filing/0000911916-20-000136#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Brickell Biotech, Inc.","issuer_ticker":"BBI","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0001758842","owner_name":"McAvoy David R.","owner_display_name":"McAvoy David R.","owner_url":"/insider/0001758842","role":"Officer (General Counsel and CCO)","role_mark":"O","role_mark_label":"Officer (General Counsel and CCO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and CCO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30435.0,"shares_display":"30,435","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":59357.0,"shares_owned_after_display":"59,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-22","filed_date":"2020-06-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","url":"/issuer/0000818686","role":"Officer (EVP, Chief Legal Officer)","n_filings":2,"first_seen":"2025-03-06","last_seen":"2025-09-09"},{"type":"issuer","type_label":"ISSUER","cik":"0000819050","name":"Brickell Biotech, Inc.","url":"/issuer/0000819050","role":"Officer (General Counsel and CCO)","n_filings":4,"first_seen":"2020-06-22","last_seen":"2021-07-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001758842","retrieved_at":"2026-08-23T14:35:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}